Nyxoah (ENXTBR:NYXH) Price Target Reduced by 17.36% to 10.07
Written by Emily J. Thompson, Senior Investment Analyst
Source: NASDAQ.COM
Updated: 1 hour ago0mins
Price Target Revision: The average one-year price target for Nyxoah has been revised down to €10.07 per share, a decrease of 17.36% from the previous estimate of €12.19, but still represents a potential increase of 135.34% from the current closing price of €4.28.
Fund Sentiment: There are currently 50 funds reporting positions in Nyxoah, a slight decrease of 1.96% from the previous quarter, with the average portfolio weight dedicated to Nyxoah increasing by 39.55%.
Shareholder Activity: Vestal Point Capital reduced its holdings by 26.60%, while FCPGX increased its allocation by 10.01%. Other funds like BlackRock Health Sciences Trust II significantly decreased their shares by 110.87%.
Fintel Overview: Fintel provides comprehensive investing research tools, including fundamentals, analyst reports, and fund sentiment, aimed at individual investors and small hedge funds.
About the author
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
